Aquestive Therapeutics, Inc (AQST) insider trading

Every open-market stock purchase and sale by Aquestive Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Insiders sold $2.6M over the last 12 months (13 sales). No open-market buys.
  • Last insider buy: Peter E. Boyd (VP), $4K, 4 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $2.6M (13 sales). Last close $3.93 on Jun 4, 2026.

Recent AQST insider trades

DateInsiderTradeValue
Jun 23, 2026Julie Krop (Insider)Sold$125K
Jun 23, 2026Julie Krop (Insider)Bought (not open market)—
Jun 15, 2026Daniel Barber (CEO)Sold$104K
Jun 10, 2026Marco Taglietti (Insider)Bought (not open market)—
Jun 10, 2026Gregory B Brown (Insider)Bought (not open market)—
Jun 10, 2026John Cochran (Insider)Bought (not open market)—
Jun 10, 2026Abigail L. Jenkins (Insider)Sold (not open market)—
Jun 10, 2026Julie Krop (Insider)Bought (not open market)—
Jun 10, 2026Timothy E Morris (Insider)Bought (not open market)—
Jun 8, 2026Sherry Korczynski (C-suite exec)Sold (not open market)—
May 18, 2026Thomas A. Zalewski (C-suite exec)Bought (not open market)—
May 18, 2026Thomas A. Zalewski (C-suite exec)Bought (not open market)—
May 15, 2026Daniel Barber (CEO)Sold$35.4K
May 15, 2026Melina Cioffi (VP)Sold (not open market)$7K
May 7, 2026Lori J Braender (Officer)Sold (not open market)$574K
May 5, 2026Daniel Barber (CEO)Sold (not open market)$1.4M
May 5, 2026A Ernest Toth Jr (CFO)Sold (not open market)$387K
May 5, 2026Lori J Braender (Officer)Sold (not open market)$318K
May 5, 2026Cassie Jung (COO)Sold (not open market)$304K
May 5, 2026Peter E. Boyd (C-suite exec)Sold (not open market)$237K
Mar 10, 2026Daniel Barber (CEO)Sold$754K
Mar 10, 2026A Ernest Toth Jr (CFO)Sold$243K
Mar 10, 2026Cassie Jung (COO)Sold$191K
Mar 10, 2026Lori J Braender (C-suite exec)Sold$167K
Mar 10, 2026Peter E. Boyd (C-suite exec)Sold$124K

Who's trading AQST

Get free alerts when an insider at Aquestive Therapeutics, Inc files a new trade →